Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Novartis to Acquire Tourmaline Bio, Boosting Cardiovascular Pipeline with Pacibekitug for ASCVD Treatment

Read more

Health Canada Approves Bylvay for Treating Cholestatic Pruritus in Alagille Syndrome Patients

Read more

Servier Acquires Promising Fragile X Syndrome Treatment, Key Genetic Cause of Autism

Read more

Lilly’s Jaypirca (pirtobrutinib) Shows Significant Progression-Free Survival Benefit in Treatment-Naïve CLL/SLL

Read more

Lilly’s Olomorasib Gets FDA Breakthrough Therapy Nod for New Metastatic KRAS G12C Lung Cancer Treatment

Read more

Argo Biopharma Secures Multi-Asset License and Option Deals with Novartis for Cardiovascular Drug Candidates

Read more

Health Canada Approves ELAHERE for Platinum-Resistant Ovarian Cancer

Read more

Avadel Expands Sleep Medicine Portfolio with Exclusive Valiloxybate License from XWPharma

Read more

FDA Boosts Rare Disease Drug Development with New Evidence Guidelines

Read more

Gilead Partners with PEPFAR to Provide Twice-Yearly HIV Prevention to 2 Million People in Low-Income Countries

Read more

Posts pagination

Previous Page 1 of 923 … Page 47 of 923 … Page 923 of 923 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version